Ekso Bionics
(NASDAQ) EKSO
Ekso Bionics Financials at a Glance
Market Cap
$37.56M
Revenue (TTM)
$12.80M
Net Income (TTM)
$11.70M
EPS (TTM)
$-5.06
P/E Ratio
-2.08
Dividend
$0.00
Beta (Volatility)
0.83 (Low)
Dividend
$0.00
Beta (Volatility)
0.83 (Low)
Price
$10.50
Volume
2,880
Open
$10.39
Price
$10.50
Volume
2,880
Open
$10.39
Previous Close
$10.50
Daily Range
$10.00 - $10.50
52-Week Range
$2.73 - $13.50
Dividend
$0.00
Beta (Volatility)
0.83 (Low)
Price
$10.50
Volume
2,880
Open
$10.39
Previous Close
$10.50
Daily Range
$10.00 - $10.50
52-Week Range
$2.73 - $13.50
EKSO News
EKSO: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Ekso Bionics
Industry
Healthcare Equipment and Supplies
Sector
Health CareEmployees
55
CEO
Scott G. Davis
Website
www.eksobionics.comHeadquarters
San Rafael, CA 94804, US
EKSO Financials
Key Financial Metrics (TTM)
Gross Margin
53%
Operating Margin
-1%
Net Income Margin
-91%
Return on Equity
-108%
Return on Capital
-1%
Return on Assets
-58%
Earnings Yield
-48.08%
Dividend Yield
0.00%
Payout Ratio
-1.93%
Stock Overview
Market Cap
$37.56M
Shares Outstanding
3.56M
Volume
2.88K
Short Interest
0.00%
Avg. Volume
2.13M
Financials (TTM)
Gross Profit
$6.84M
Operating Income
$13.33M
EBITDA
$9.81M
Operating Cash Flow
$11.80M
Capital Expenditure
$188.00K
Free Cash Flow
$11.99M
Cash & ST Invst.
$1.17M
Total Debt
$2.64M
Ekso Bionics Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$3.14M
-38.3%
Gross Profit
$1.67M
-38.4%
Gross Margin
53.22%
N/A
Market Cap
$37.56M
N/A
Market Cap/Employee
$615.70K
N/A
Employees
61
N/A
Net Income
$4.67M
-36.9%
EBITDA
$3.76M
-27.2%
Quarterly Fundamentals
Net Cash
$1.47M
-387.6%
Accounts Receivable
$7.31M
+1.0%
Inventory
$4.82M
+5.5%
Long Term Debt
$945.00K
-78.1%
Short Term Debt
$1.69M
+0.8%
Return on Assets
-58.15%
N/A
Return on Invested Capital
-1.16%
N/A
Free Cash Flow
$4.38M
-201.3%
Operating Cash Flow
$4.33M
-202.2%